What is the minimum investment required for PCD Pharma Franchise?

The minimum investment typically ranges from ₹2–5 lakhs, depending on territory size, product selection and initial stock planning. Our team will help structure this based on your goals.

What documents are required to become a franchise partner?

You will need a valid Drug License, GST registration and basic KYC documents. Our team will guide you through every step of the documentation process.

What kind of support and training do you provide?

We provide product training, sales guidance, marketing materials, doctor coverage strategies, and ongoing business support through dedicated account managers.

How are territories allocated and protected?

Territories are allocated based on mutual agreement and market mapping. We offer genuine monopoly rights with clear documentation to avoid internal competition.

What is the expected profit margin and ROI timeline?

Average profit margins range from 25–30%, with typical ROI timelines between 12–18 months, depending on your execution and territory potential.

How do you ensure product quality and compliance?

All products are manufactured in WHO-GMP certified facilities with 100% quality testing, robust documentation and DCGI approvals as applicable.

What is the delivery timeline and process?

Dispatch timelines depend on order size and location, but we maintain a strong track record of timely delivery across India with proper packaging and logistics partners.

Antibiotics/Anti-infectives

Stecix-DS

Cefixime 50mg

Pack: 30ML
Format: With Carton

MRP₹51.03

A high-efficacy, third-generation cephalosporin antibacterial suspension designed for the targeted treatment of acute bacterial infections in pediatric patients. STECIX-DS 50MG provides powerful bactericidal action against a wide range of pathogens, ensuring rapid recovery from respiratory, urinary, and enteric infections.

About The Product

Key Benefits

Advanced Third-Generation Cephalosporin Action

Cefixime 50mg is a potent third-generation cephalosporin that works by inhibiting bacterial cell wall synthesis. It is highly effective against a broad spectrum of Gram-positive and Gram-negative bacteria, offering superior clinical outcomes in treating infections that may be resistant to older penicillins or first-generation antibiotics.

Targeteddd Management of Enteric (Typhoid) Fever

STECIX-DS is a gold-standard choice for the treatment of uncomplicated typhoid fever in children. Its excellent penetration into the intestinal tissues and stability against bacterial defenses allow it to effectively eliminate Salmonella typhi, reducing high-grade fever and preventing long-term complications.

Superior Respiratory and Ear Infection Coverage

This formulation is highly effective in treating acute otitis media (middle ear infection), tonsillitis, and pharyngitis. By reaching therapeutic concentrations in the upper respiratory tract, Cefixime rapidly clears the infection, providing relief from pain, swelling, and difficulty swallowing.

High Stability Against Beta-Lactamases

A key advantage of Cefixime is its exceptional stability in the presence of beta-lactamase enzymes produced by resistant bacteria. This ensures that STECIX-DS remains active and potent where other medications might fail, providing a reliable defense against tough pediatric pathogens.

Optimized Pediatric Bioavailability

The suspension is designed for consistent and rapid absorption in the gastrointestinal tract. This ensures that the active medicine enters the bloodstream quickly, leading to a faster reduction in symptoms and ensuring the child returns to their normal activity levels sooner.

Double Strength for Accurate Dosing

The "DS" (Double Strength) concentration allows for the administration of a precise, smaller volume of liquid to reach the required therapeutic dose. This improves patient compliance, as it is easier for parents to administer and more comfortable for children to swallow.

Indication Typhoid (Enteric) Fever, Acute Otitis Media (Middle Ear Infection), Tonsillitis and Pharyngitis, Urinary Tract Infections (UTIs), Acute Bronchitis, Skin and Soft Tissue Infections.

Indications

Typhoid (Enteric) Fever
Acute Otitis Media (Middle Ear Infection)
Tonsillitis and Pharyngitis
Urinary Tract Infections (UTIs)
Acute Bronchitis
Skin and Soft Tissue Infections.

Product descriptions, dosage forms, and compositions listed on the website are for reference by licensed practitioners and distributors only.

Stecix-DS